[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592360":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":24,"responsibleParty":34,"collaborators":24,"id":37,"slug":24,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":24,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":24,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":60,"whyStopped":24,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":24},{"fullName":5,"class":6},"University of Calgary","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Creatine monohydrate","EXPERIMENTAL","8 g\u002Fday creatine monohydrate",[13],"Dietary Supplement: Creatine monohydrate",{"label":15,"type":16,"description":17,"interventionNames":18},"Maltodextrin","PLACEBO_COMPARATOR","8 g\u002Fday maltodextrin",[13],[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"DIETARY_SUPPLEMENT","8 g\u002Fday creatine monohydrate powder",[9,15],null,[26],{"name":27,"affiliation":5,"role":28},"Keely A Shaw, PhD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":24,"email":33},"CONTACT","3064587102","keely.shaw@ucalgary.ca",{"type":28,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Keely Shaw","Postdoctoral Associate","100592360",false,"NCT06992414","Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19","Exploring Creatine Supplementation for Improved Exercise Capacity and Reduced Fatigue in Long COVID-19: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Experiencing symptoms at least 3 months after a COVID-19 diagnosis confirmed by positive polymerase chain reaction (PCR) test\n* Experiencing post-exertional malaise, as per the DePaul Symptom Questionnaire\n\nExclusion Criteria:\n\n* Allergy or intolerance to creatine monohydrate or maltodextrin\n* Supplemented with creatine in the past eight weeks\n* orthopaedic injury or condition that would prevent exercise testing\n* change in medication related to Long COVID symptom management in the past month.","ALL","18 Years","65 Years",{"count":47,"type":48},24,"ESTIMATED","INTERVENTIONAL",[51],"NA","Individuals living with Long COVID often experiencing a degree of undue fatigue after physical or cognitive exertion secondary to the condition, timed post-exertional malaise 9PEM). This trial aims to explore the efficacy of creatine monohydrate in managing PEM",[54],"Long COVID Fatigue",[56,57,58,59],"creatine","post-exertional malaise","exercise","nutraceutical","NOT_YET_RECRUITING","2025-05-27",{"date":63,"type":64},"2025-05-31","ACTUAL",{"date":66,"type":48},"2025-07-02",{"date":68,"type":48},"2026-10-31",{"name":5,"class":6}]